profit from every $100 of sales.
$0$100
GridAI Technologies
$3.74-31.00% today
+1.9% in 1 year
1-year low $2.011-year high $6.80
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What GridAI Technologies sold, what it kept, and what it did with the cash.
Sales went from $0 in 2022 to $36,251 in 2025, with -$6.39 million of profit last year.
SalesProfit
GridAI Technologies vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| GridAI Technologies | No profit yet | ||
 Vertex Pharmaceuticals | 34.5× · Expensive | ||
 Regeneron Pharmaceuticals | 21.9× · Fair price | ||
 Moderna | No profit yet | ||
 CSL | 22.0× · Fair price |
AI analysis
An AI analyst reads GridAI Technologies's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 0 | 0 | 0 | |
| – | – | 0 | -1 | |
| -13 | -16 | -16 | -7 | |
| -15 | -16 | -16 | -7 | |
| -15 | -16 | -18 | -6 | |
| -1,250.82 | -143.64 | -15.99 | -4.16 | |
| – | – | – | -1,813.6% | |
| – | – | – | -19,540.0% | |
| – | – | – | -17,634.4% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 5 | 7 | 85 | 49 |
| Cash | 1 | 4 | 0 | 1 |
| Total debt | 1 | 1 | 0 | 2 |
| Total liabilities | 3 | 3 | 28 | 20 |
| 3 | 4 | 58 | 24 | |
| 0 | 0 | 1 | 2 | |
| -318.4% | -281.3% | -21.3% | -21.5% | |
| -533.5% | -438.4% | -31.2% | -27.0% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -22 | -12 | -9 | -6 | |
| – | 1 | – | – | |
| -22 | -13 | -9 | -6 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 1 | 1 | 1 | 1 |
Valuation
- –
- –
- –
- 0.9×
- 917.1×
- –
- –
- -17.2%
- -19.2%
- 0.0%
Profitability
- -1,813.6%
- -19,540.0%
- -17,634.4%
- -12,492.6%
- -27.6%
- 9.1%
- -18.7%
- -18.2%
- -31.1%
- 2,069.6%
Growth
- –
- –
- +38.1%
- –
- +425.2%
Financial health
- –
- 0.11
- 5.2%
- 200.9×
- 0.16
- 0.16
- 0.00
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 14%of 952
Bottom 5%of 987
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Feb 25, 2026 | -2.92 | -11,340.00 | +100.0% |
| Nov 19, 2025 | -0.64 | – | – |
| Aug 14, 2025 | -0.14 | – | – |
| May 15, 2025 | -0.63 | – | – |
| Apr 4, 2025 | -2.61 | -0.41 | −536.6% |
| Nov 13, 2024 | -1.32 | -0.96 | −37.5% |
| Aug 26, 2024 | -3.84 | -1.55 | −147.7% |
| May 14, 2024 | 0.38 | -2.43 | +115.6% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/6Passes 0 of 6. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
41No pass
Benjamin Graham
47No pass
Philip Fisher
48No pass
Peter Lynch
–Not enough data
Joel Greenblatt
0No pass
Charlie Munger
41No pass
Terry Smith
31No pass
Questions about GridAI Technologies
Is GridAI Technologies a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 6 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the GridAI Technologies AI analysis
What does GridAI Technologies do?
GridAI Technologies Corp. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. It is in Biotechnology.
Does GridAI Technologies pay a dividend?
No. GridAI Technologies does not pay a dividend at the moment.
Is GridAI Technologies stock halal?
Yes. GridAI Technologies passes our halal screen: its business is permitted and its debt is 7% of its market value, under the 30% limit. How we check
How has GridAI Technologies stock done over the past year?
Up 1.9% over the past twelve months, to $3.74. It traded between $2.01 and $6.80 and is 45.0% below its high.
Who are GridAI Technologies's competitors?
The largest listed companies in the same industry are Vertex Pharmaceuticals, Regeneron Pharmaceuticals, Moderna and CSL. The peers table on this page compares their profit, growth and price with GridAI Technologies's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.